| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,686 |
12,681 |
$811K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,405 |
2,326 |
$179K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,247 |
2,185 |
$170K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,764 |
1,722 |
$146K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,135 |
1,957 |
$143K |
| 90651 |
|
950 |
931 |
$34K |
| 90670 |
|
1,348 |
1,270 |
$31K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,301 |
2,162 |
$29K |
| 90686 |
|
2,438 |
2,287 |
$28K |
| 90697 |
|
620 |
590 |
$27K |
| 90671 |
|
223 |
213 |
$23K |
| 90734 |
|
742 |
727 |
$19K |
| 90677 |
|
316 |
301 |
$17K |
| 90680 |
|
1,049 |
997 |
$16K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
7,974 |
7,477 |
$13K |
| 90620 |
|
386 |
383 |
$12K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
831 |
527 |
$12K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
396 |
371 |
$12K |
| 90633 |
|
907 |
885 |
$12K |
| 99173 |
|
4,669 |
4,511 |
$11K |
| 99381 |
|
158 |
121 |
$9K |
| 90461 |
|
3,495 |
3,305 |
$8K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
99 |
96 |
$8K |
| 90648 |
|
782 |
737 |
$8K |
| 99383 |
|
64 |
64 |
$6K |
| 90723 |
|
371 |
352 |
$6K |
| 99177 |
|
1,091 |
1,060 |
$5K |
| 90715 |
|
239 |
234 |
$4K |
| 90710 |
|
116 |
115 |
$3K |
| 96127 |
|
670 |
661 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
30 |
29 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
27 |
27 |
$2K |
| 99188 |
|
89 |
87 |
$2K |
| 90716 |
|
78 |
76 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
104 |
101 |
$2K |
| 90656 |
|
122 |
122 |
$2K |
| 90696 |
|
113 |
113 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
49 |
45 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
37 |
37 |
$1K |
| 92551 |
|
112 |
109 |
$1K |
| 90707 |
|
55 |
52 |
$806.82 |
| 90744 |
|
58 |
58 |
$661.91 |
| 90685 |
|
54 |
51 |
$578.84 |
| 90621 |
|
22 |
21 |
$552.15 |
| 85018 |
|
244 |
234 |
$545.86 |
| 99000 |
|
311 |
294 |
$524.48 |
| 90698 |
|
47 |
46 |
$515.90 |
| 87807 |
|
40 |
37 |
$494.54 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
26 |
24 |
$220.05 |
| 90700 |
|
13 |
13 |
$143.00 |
| 36416 |
|
331 |
317 |
$79.17 |